These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38367862)

  • 1. Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosis.
    Wang K; Chen H; Zheng J; Chen J; Chen Y; Yuan Y
    J Control Release; 2024 Apr; 368():219-232. PubMed ID: 38367862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy.
    Wang X; Zhang W; Zeng S; Wang L; Wang B
    Acta Biomater; 2024 Feb; 175():262-278. PubMed ID: 38141933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential Nano-Penetrators of Capillarized Liver Sinusoids and Extracellular Matrix Barriers for Liver Fibrosis Therapy.
    Zhang LF; Wang XH; Zhang CL; Lee J; Duan BW; Xing L; Li L; Oh YK; Jiang HL
    ACS Nano; 2022 Sep; 16(9):14029-14042. PubMed ID: 36036898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy.
    Zhou L; Liang Q; Li Y; Cao Y; Li J; Yang J; Liu J; Bi J; Liu Y
    Acta Biomater; 2022 Oct; 152():235-254. PubMed ID: 36087869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CREKA-modified liposomes target activated hepatic stellate cells to alleviate liver fibrosis by inhibiting collagen synthesis and angiogenesis.
    Li R; Zhang J; Liu Q; Tang Q; Jia Q; Xiong Y; He J; Li Y
    Acta Biomater; 2023 Sep; 168():484-496. PubMed ID: 37392933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic stellate cells specific liposomes with the Toll-like receptor 4 shRNA attenuates liver fibrosis.
    Zhang Y; Li Y; Mu T; Tong N; Cheng P
    J Cell Mol Med; 2021 Jan; 25(2):1299-1313. PubMed ID: 33336563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-Based Bionic Delivery System Breaks Through the Capillary Barrier of Liver Sinusoidal Endothelial Cells and Inhibits the Activation of Hepatic Stellate Cells.
    Sun D; Du X; Cao X; Wu B; Li S; Zhao Y; Liu T; Xu L; Huang H
    Mol Pharm; 2024 Apr; 21(4):2043-2057. PubMed ID: 38471114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senescence of Hepatic Stellate Cells by Specific Delivery of Manganese for Limiting Liver Fibrosis.
    Gu L; Zhao C; Wang Y; Wang C; Yin X; Ye Q; Liu Y; Zou X; Wang L; Zhuge Y; Wu J; Zhang F
    Nano Lett; 2024 Jan; 24(4):1062-1073. PubMed ID: 38164915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells.
    Chai NL; Fu Q; Shi H; Cai CH; Wan J; Xu SP; Wu BY
    World J Gastroenterol; 2012 Aug; 18(31):4199-206. PubMed ID: 22919254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice.
    Mormone E; Lu Y; Ge X; Fiel MI; Nieto N
    Gastroenterology; 2012 Mar; 142(3):612-621.e5. PubMed ID: 22138190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential delivery for hepatic fibrosis treatment based on carvedilol loaded star-like nanozyme.
    Lu Q; Zhou Y; Xu M; Liang X; Jing H; Wang X; Li N
    J Control Release; 2022 Jan; 341():247-260. PubMed ID: 34826531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of Sinusoid Fenestrae Followed by Targeted Nanoassembly Delivery of an Anti-Fibrotic Agent Improves Treatment Efficacy in Liver Fibrosis.
    Li F; Zhao Y; Cheng Z; Wang Y; Yue Y; Cheng X; Sun J; Atabakhshi-Kashi M; Yao J; Dou J; Yu J; Zhang X; Qi Y; Li X; Qi X; Nie G
    Adv Mater; 2023 Apr; 35(17):e2212206. PubMed ID: 36862807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidative Hyaluronic Acid-Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy.
    Shinn J; Park S; Lee S; Park N; Kim S; Hwang S; Moon JJ; Kwon Y; Lee Y
    ACS Nano; 2024 Feb; 18(6):4704-4716. PubMed ID: 38288705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats.
    Xie G; Wang X; Wang L; Wang L; Atkinson RD; Kanel GC; Gaarde WA; Deleve LD
    Gastroenterology; 2012 Apr; 142(4):918-927.e6. PubMed ID: 22178212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis.
    Li Y; Pu S; Liu Q; Li R; Zhang J; Wu T; Chen L; Li H; Yang X; Zou M; Xiao J; Xie W; He J
    J Control Release; 2019 Jun; 303():77-90. PubMed ID: 31004666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vicious Cycle-Breaking Lipid Nanoparticles Remodeling Multicellular Crosstalk to Reverse Liver Fibrosis.
    Zhang LF; Deng WQ; Huang QW; Zhang JJ; Wang Y; Zhou TJ; Xing L; Jiang HL
    Adv Mater; 2024 Apr; 36(16):e2311474. PubMed ID: 38194906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Stellate Cell: A Double-Edged Sword in the Liver.
    Luo N; Li J; Wei Y; Lu J; Dong R
    Physiol Res; 2021 Dec; 70(6):821-829. PubMed ID: 34717063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dually fibronectin/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosis.
    Li Y; Zhang T; Zhang J; Liu Q; Jia Q; Chen W; Tang Q; Xiong Y; Xia Y; Xu Y; Mo L; Huang Y; He J
    Biomaterials; 2023 Oct; 301():122232. PubMed ID: 37418856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis.
    El-Mezayen NS; El-Hadidy WF; El-Refaie WM; Shalaby TI; Khattab MM; El-Khatib AS
    J Control Release; 2017 Nov; 266():226-237. PubMed ID: 28965860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.